Article
Comprehensive molecular biomarker identification in breast cancer brain metastases.
Journal of translational medicine - 29 Dec 2017
Schulten Hans-Juergen, Bangash Mohammed, Karim Sajjad, Dallol Ashraf, Hussein Deema, Merdad Adnan, Al-Thoubaity Fatma K, Al-Maghrabi Jaudah, Jamal Awatif, Al-Ghamdi Fahad, Choudhry Hani, Baeesa Saleh S, Chaudhary Adeel G, Al-Qahtani Mohammed H
Abstract excerpt
BACKGROUND: Breast cancer brain metastases (BCBM) develop in about 20-30% of breast cancer (BC) patients. BCBM are associated with dismal prognosis not at least due to lack of valuable molecular therapeutic targets. The aim of the study was to identify new molecular biomarkers and targets in BCBM by using complementary state-of-the-art techniques. METHODS: We compared array expression profiles of three BCBM with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
